Skip to main content
Caplight Logo









iVeena Delivery Systems

iVeena Delivery Systems

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://iveenamed.com/

Last Round

Grant

Sep 18, 2025

Total Funding Raised

$5.57M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

iVeena Delivery Systems is a clinical-stage ophthalmology company that develops disease-modifying pharmacologic innovations for the treatment of refractive diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceuticalophthalmologypediatric myopiakeratoconuseye dropsdrug developmentrefractive eye diseasemyopia controlpharmacologic treatmentcollagen crosslinkingnon-invasive therapybiotech licensingsmall business innovation researchSBIReye care innovation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

iVeena Delivery Systems Comparables

Compare iVeena Delivery Systems with similar companies based on industry and business-model similarity.

iVeena Delivery Systems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sydnexis
84%
Nevakar Inc.
84%
Theialife Sciences
79%

iVeena Delivery Systems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 18, 2025
Series B ExtensionFeb 5, 2025
GrantOct 26, 2023
Series BOct 13, 2021
Series BAug 25, 2020
Grant
Dec 14, 2017

Key People

Founding team and executive leadership

Mike Burr

Cofounder & Chief Operating Officer

Founding Team

Sarah Molokhia

Co-founder & Chief Scientific Officer

Founding Team

iVeena Delivery Systems Investors

Notable investors and investment history

iVeena Delivery Systems investors
InvestorRounds
National Eye Institute (NIH)Grant
Park City AngelsSeries A
National Institutes of Health (NIH)Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors grew 266% MoM, reaching 3.3K.

  • Sep 19, 2025

    Received $2M grant from National Eye Institute for myopia eye drops.

iVeena Delivery Systems Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

iVeena Delivery Systems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about iVeena Delivery Systems's valuation, stock price, and market status.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range8
Year Founded2006
Last FundingSep 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?